CoreAge Rx vs SnagRx: Buy Once, or Prepay the Year

MyGLP1Reviews is an independent review site. We are not a medical provider and we are not affiliated with either company. Both CoreAge Rx and SnagRx pay us a commission if you sign up through our links, and both links are labelled. See our review method and affiliate disclosure.
The short version

Month to month, these two cost the same: $99 for compounded semaglutide from either. The difference is not price, it is what happens next.

CoreAge Rx sells one-time purchases. Refills are ordered manually, and its FAQ says there are “no membership fees, no auto-rebills, and no surprise charges.” Its refund policy, dated 13 August 2026, says something else: CoreAge “may offer both one-time purchases and subscription plans with automatic renewals.” Confirm which one you are buying on the checkout screen, because the paperwork no longer agrees with itself. SnagRx is a subscription with automatic recurring billing and a 72-hour cancellation notice requirement — and if you take its advertised $69 rate, you are buying twelve months up front as a single $828 charge that renews for another twelve unless you cancel.

So the cheapest year here is SnagRx at $828, and the lowest-commitment year is CoreAge at $1,188 with nothing to cancel.

CoreAge — check what you are buying ↗SnagRx — $828 for the year ↗

Both links above are affiliate links.

A subscription, or not a subscription

This is the only structural difference in the category that reliably changes how much people end up paying, because most of the money lost on GLP-1 telehealth is lost to renewals nobody meant to authorise.

CoreAge Rx removes the mechanism. Its orders are one-time purchases and refills are placed manually, so there is no renewal date, no notice period and no cancellation to forget. That is genuinely unusual — it is the reason CoreAge sits at the top of our no-subscription comparison.

SnagRx keeps the mechanism and is explicit about it. Its terms state you are purchasing a recurring subscription, that your card will be charged automatically, and that charges continue until you cancel. Cancellation needs to reach them at least 72 hours before the billing date; miss that and you are charged, with the cancellation taking effect the cycle after.

Side by side

  CoreAge Rx SnagRx
Semaglutide From $99, the same price at every dose $99 monthly, or $69/month as a $828 twelve-month charge
Tirzepatide From $149, the same price at every dose $149 monthly, or $119/month as a $1,428 twelve-month charge
Structure One-time purchases. Refills ordered manually Recurring subscription. Multi-month terms billed once and renewed for the same length
Notice to stop None — there is nothing to cancel 72 hours before the billing date
Refunds Free cancellation only before a provider approves the prescription and it reaches the pharmacy. After that all sales are final Refundable only before the medication is ordered, which for new patients is generally at intake submission. Full refund if a provider disqualifies you
The catch Cancel a 6 or 12-month plan early and medication already shipped is re-billed at the 3-month rate. The site also advertises GLP-1 treatment “from $199/mo” higher up the page The advertised $69 is not a monthly bill. Missing a 72-hour window on an annual plan means a fresh $828 charge
FDA status Compounded, not FDA-approved Compounded, not FDA-approved

The annual arithmetic

Twelve months of compounded semaglutide, on the published figures:

  • SnagRx, twelve-month term: $828, paid as one charge on day one
  • CoreAge Rx, monthly: $1,188 if you reorder twelve times at $99
  • SnagRx, monthly: $1,188 — identical to CoreAge, with a renewal date attached

The $360 gap between SnagRx’s prepaid year and either monthly route is the price of committing. Whether that is a good trade depends entirely on how confident you are that you will still be taking this medication in month eleven, and neither company refunds an unused portion once the medication has been ordered.

Each has a catch worth naming

CoreAge: the re-billing rule. If you buy a 6 or 12-month plan and stop early, medication already shipped is re-priced at the 3-month rate, which claws back the discount you were given for committing. That is not a subscription, but it behaves like one financially if you buy a longer plan. Buying month by month avoids it entirely. Separately, its own site advertises GLP-1 treatment “from $199/mo” higher up the page than the $99 figure, which we could not reconcile.

SnagRx: the advertised price is a twelve-month prepayment, and its marketing describes “locked-in flat pricing for life” while the terms say promotional pricing applies only for the period stated at checkout. It is also operated by the same company as Embody — see Embody vs SnagRx if you are weighing both.

Which one to pick

CoreAge Rx if you want to be able to stop without doing anything, or if you are not yet sure this medication suits you. Buy month by month rather than a longer plan, and the re-billing rule never applies to you.

SnagRx if you have already been on a GLP-1, know you tolerate it, and want the lowest published annual figure of the two. Pay for the year, then put the cancellation notice in your calendar eleven months out, not twelve.

Buy once, no subscription — CoreAge Rx ↗See SnagRx term pricing ↗

Both links above are affiliate links. Ordering on this site is never sold; see our affiliate disclosure.

Compare this against the rest of the market

How we sourced this

CoreAge figures, the one-time purchase structure, the early-cancellation re-billing rule and the “from $199/mo” inconsistency are carried from our CoreAge Rx review, read on the company’s own site in August 2026 and dated there. SnagRx prices, the billed-once structure, the renewal rule, the 72-hour notice requirement and the promotional-pricing clause are quoted from its published Terms & Conditions and Cancellation and Refund Policy, read on 17 August 2026. Annual figures are our arithmetic. If either company changes its pricing, tell us and we will correct this page.

Medical note

Nothing on this page is medical advice. GLP-1 medicines are prescription drugs with real risks, including a boxed warning for thyroid C-cell tumours on the branded products, and they are not appropriate for everyone. Compounded versions are not FDA-approved and are not generic equivalents. Talk to a clinician who can see your full history before starting, stopping or changing a dose, and tell them about every other medicine you take.